Rosenberg, Aaron <br/><br/>
Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor.  [electronic resource] 

 -  Expert opinion on investigational drugs  Jun 2013 
 - 787-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7658 
<br/><br/><label>Standard No.: </label>10.1517/13543784.2013.787409  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Benzamides--pharmacology<br/>Clinical Trials as Topic<br/>Disease-Free Survival<br/>Drug Evaluation, Preclinical<br/>Humans<br/>Imatinib Mesylate<br/>Male<br/>Molecular Targeted Therapy<br/>Piperazines--pharmacology<br/>Platelet-Derived Growth Factor--metabolism<br/>Prostatic Neoplasms--drug therapy<br/>Pyrimidines--pharmacology<br/>Receptors, Platelet-Derived Growth Factor--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Survival Rate